Reference no: EM133330050
Assignment:
Introduction
January 2017
"When Ian Read, an accountant and company lifer, took over as Pfizer's chief executive in December 2010, the drug firm was facing the impending patent expiration of Lipitor, the best- selling drug ever made, and the utter failure of one of the most lavishly funded research laboratories on the planet to develop much of anything. The stock was suffering, and Read's predecessor-Jeffrey Kindler, a bearlike lawyer hired from McDonald's-had just spent $68 billion to buy rival drug maker Wyeth in a Hail Mary strategy shift. Now Read had to make it work."
Company and Industry Background
Pfizer was established in 1849 in Brooklyn, New York, by cousins Charles Pfizer and Charles Erhart with a loan of $2,500 from Pfizer's father. Today, 167 years later, Pfizer Inc. has international revenues of $49 billion, which makes it the second-largest pharmaceutical manufacturer in the world. Despite Pfizer's success, the company has faced many challenges over the last few decades. The pharmaceutical industry is heavily influenced by legal, political, and technological forces, and all indications are that the industry will continue to experience dramatic changes.
This is the case study sample can anybody give answers to these questions
Describe the current corporate level strategy employed by the company and provide evidence from the case to support your opinion. Discuss all SBUs and synergies between BUs.
• Provide one example of how the company tried to employ each of the three concentration strategies, and evaluate their effectiveness.
• How did the company use vertical integration to increase their capabilities? Provide three arguments that they were successful or not.